NCT07544459

Brief Summary

To evaluate the effectiveness of mindfulness-based stress reduction (MBSR) combined with aerobic training on treatment adherence, kinesiophobia, heart rate variability (HRV), exercise tolerance, and psychological stress response in patients with coronary heart disease (CHD) post-percutaneous coronary intervention (PCI). Post-PCI patients (n = 150) were randomly assigned to an observation group (receiving combined MBSR and aerobic training) and a control group (receiving aerobic training only). Treatment adherence, the Tampa Scale for Kinesiophobia-Heart (TSK-SV Heart), HRV parameters, exercise tolerance, and psychological stress responses were assessed before and after the intervention. Psychological assessments included the Self-Rating Anxiety Scale (SAS) and the Self-Rating Depression Scale (SDS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2025

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2025

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 15, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

1.3 years

First QC Date

April 15, 2026

Last Update Submit

April 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Depression Symptoms

    The SDS is a 20-item self-rating scale used to assess the severity of depressive symptoms. Each item is scored on a 4-point Likert scale. Total scores range from 20 to 80. Scores below 53 are considered normal; higher scores indicate more severe depression. The sample size calculation (n=150) was based on an estimated effect size (Cohen's d) of 0.54 for this measure.

    Baseline (pre-intervention) and immediately post-intervention (after 8 weeks).

Secondary Outcomes (5)

  • Change in Anxiety Symptoms

    Baseline and post-intervention (8 weeks).

  • Change in Treatment Adherence Score

    Baseline and post-intervention (8 weeks).

  • Change in Kinesiophobia Level

    Baseline and post-intervention (8 weeks).

  • Change in Standard Deviation of Normal-to-Normal RR Intervals

    Baseline and post-intervention (8 weeks).

  • Change in Standard Deviation of Average Normal-to-Normal RR Intervals in 5-minute Segments

    Baseline and post-intervention (8 weeks).

Study Arms (2)

observation group

EXPERIMENTAL

receiving combined MBSR and aerobic training

Behavioral: observation group

control group

NO INTERVENTION

receiving aerobic training only

Interventions

Patients participated in 2-hour daily MBSR sessions conducted in a designated hospital rehabilitation room. After discharge, patients were instructed to continue weekly home-based practice for two months. The MBSR components included: (a) Mindful breathing: Conducted in a quiet, comfortable, and distraction-free environment with the patient seated upright, shoulders and neck relaxed. Patients were guided to focus on their breath, feeling the sensation of air flowing in and out, for 10 to 15 minutes per session, 2 to 3 times daily. If thoughts or emotions arose during the session, attention was gently redirected to the breath. (b) Mindfulness meditation: Also performed in a quiet setting, patients were guided to adopt an accepting attitude toward negative emotions without resistance or avoidance. The goal was to allow emotions to arise and naturally dissipate. Each session lasted 20 to 30 minutes, once or twice daily. (c) Body scanning: Patients were guided to assume a comfortable postu

observation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of coronary heart disease (CHD)
  • Successful percutaneous coronary intervention (PCI) procedure
  • No contraindications to rehabilitation exercise
  • Provision of written informed consent by the patient and their legal guardian

You may not qualify if:

  • Coexisting severe organic disease (e.g., severe valvular disease, advanced kidney or liver failure)
  • Malignancy (active or history of cancer within recent years)
  • Cognitive impairment (sufficient to preclude understanding or compliance with mindfulness-based stress reduction or exercise instructions)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Linyi People's Hospital

Linyi, Shandong, 276000, China

Location

MeSH Terms

Conditions

Coronary DiseaseKinesiophobia

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesPhobic DisordersAnxiety DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 15, 2026

First Posted

April 22, 2026

Study Start

October 15, 2023

Primary Completion

January 17, 2025

Study Completion

January 25, 2025

Last Updated

April 22, 2026

Record last verified: 2026-04

Locations